Pharmaceuticals News

RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4,...

Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanism First-of-its-kind meeting spotlights...

Deborah Ascheim, M.D., former Capricor Therapeutics CMO, elected to stem cell therapy company Longeveron (LGVN) Board of Directors.

Myriad Genetics will hold its second quarter 2026 earnings conference call at 4:30 pm ET on Thursday, July 30, 2026.

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, announced the appointment of John Donoghue, Ph.D.,...

First global approval of a once-daily, orally administered, Complement Factor B inhibitorApproval based on robust efficacy and safety data from Haisco's broad completed clinical development program in...

20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock

K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen’s 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million...

Company has addressed final review items from penetration testing and finalized cybersecurity and software documentation 510(k) package submission on track for calendar H2 2026, targeting planned...

CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...